Business Context and Reporting Period
Company: Innate Pharma S.A.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: June 2021 (Report Date: June 22, 2021)
Context: This filing incorporates by reference a press release (Exhibit 99.1) dated June 22, 2021, into the company's registration statement on Form F-3. The document serves as a notification of the press release rather than a standalone financial report.
Key Financial Metrics
The provided filing text does not contain specific financial data. It is a cover sheet for a press release and does not list values for:
- Revenue
- Profit or Loss
- Cash Flow
- Margins
- Debt or Liquidity
Note: The filing text does not provide a clear value for any financial metric.
Material Changes
The filing text does not disclose specific material changes in financial position or operations compared to prior periods. The content is limited to the administrative incorporation of a press release.
Guidance, Outlook, and Risks
The provided text does not include management commentary, forward-looking guidance, risk factors, or details on contingencies. These elements would be contained within the referenced Exhibit 99.1 (Press Release), which is not included in the input text.
Investor Verification Checklist
- Review the full text of the Press Release dated June 22, 2021 (Exhibit 99.1) to understand the specific event or announcement triggering this filing.
- Consult the company's most recent Form 20-F or quarterly reports for actual financial performance data, as this Form 6-K contains no numerical figures.
- Verify the status of the Form F-3 registration statement (File No. 333-252074) to understand the context of the incorporation by reference.